Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
Hazinski
T A
TA
Vanderbilt University Medical School, Nashville, Tennessee 37232, USA.
D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D003550:Cystic Fibrosis / Q000382:microbiology*; D004311:Double-Blind Method; D006801:Humans; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D014031:Tobramycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014031:Tobramycin